Sidapvia | Use In Pregnancy & Lactation

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Use In Pregnancy & Lactation

Pregnancy: Dapagliflozin/sitagliptin combination: SIDAPVIA should not be used during pregnancy. There are no adequate and well- controlled studies of SIDAPVIA or its mono-components in pregnant women. When pregnancy is detected, treatment with SIDAPVIA should be discontinued.
Lactation: Dapagliflozin/sitagliptin combination: SIDAPVIA should not be used by a nursing woman. It is not known whether SIDAPVIA or its mono-components and/or their metabolites are excreted in human milk.
Fertility: Dapagliflozin/sitagliptin combination: The effect of SIDAPVIA or its mono-components on fertility in humans has not been studied.

Sidapvia Use In Pregnancy & Lactation

Manufacturer:

AstraZeneca

Marketer:

AstraZeneca